Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum (Q47964774)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 November 2010

Language	Label	Description	Also known as
English	Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum	scientific article published on 6 November 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

Plasmodium falciparum

1 reference

based on heuristic

inferred from title

Mycobacterium bovis

1 reference

based on heuristic

inferred from title

author name string

Asma Abdullah Nurul

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

Mohd Nor Norazmi

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

publication date

6 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

108

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

887-897

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Fate of Mycobacterium tuberculosis within murine dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immunity to blood stages of Plasmodium falciparum is dependent on a specific pattern of immunoglobulin subclass responses to multiple blood stage antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

A review of human vaccine research and development: malaria

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immunisation with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L1 gene provides protection from CRPV challenge

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

The disulfide bond structure of Plasmodium apical membrane antigen-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Cytokines and malaria parasitemia

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1(19)) variants secreted from Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense and perennial transmission: relationships with clinical malaria and with entomological inoculation rates

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Antibody specificities of children living in a malaria endemic area to inhibitory and blocking epitopes on MSP-1 19 of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

The immunology of malaria infection

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Antibodies and Plasmodium falciparum merozoites

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immunogenicity of a recombinant Mycobacterium bovis bacille Calmette-Guèrin expressing malarial and tuberculosis epitopes.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Regulation of immunity to malaria: valuable lessons learned from murine models

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

The role of TH1 and TH2 cells in a rodent malaria infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

A case for whole-parasite malaria vaccines.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-2130-5

21 January 2018

Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunity to erythrocytic stages of malarial parasites

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with a

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does the efficacy of BCG decline with time since vaccination?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical evaluation of different methods for measuring the functional activity of antibodies against malaria blood stage antigens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21057812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-010-2130-5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/21057812

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47964774&oldid=2208980565"